Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Relapsed CML After Allogeneic Stem Cell Transplantation
NCT00219726Phase 2Completed
- Sponsor
- CHU de Poitiers
- Start
- May 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in chronic myeloid leukemia (CML), sponsored by CHU de Poitiers. Started May 2002; status: completed.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00219726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219726.